Colgate-Palmolive Company (NYSE: CL) shares plunged over 5% in pre-market trading on Friday, as the consumer products giant's flat annual sales forecast overshadowed a better-than-expected fourth quarter earnings performance.
The toothpaste and household goods maker reported fiscal fourth quarter 2024 adjusted earnings of $0.91 per share, surpassing the $0.89 per share analyst consensus estimate. However, net sales for the quarter declined 0.12% year-over-year to $4.94 billion, narrowly missing expectations of $4.98 billion.
While Colgate's organic sales grew a healthy 4.3% in the fourth quarter, the company issued a tepid outlook for fiscal 2025. It expects net sales for the full year to be roughly flat compared to 2024 levels, including a mid-single-digit negative impact from foreign exchange headwinds.
The muted sales growth guidance overshadowed Colgate's upbeat forecast for organic sales growth within its long-term targeted range of 3% to 5% for 2025. On the profitability front, the company expects gross profit margin expansion and low to mid-single-digit adjusted earnings per share growth for the year.
Investors appeared to focus on the top-line weakness, driving Colgate shares down over 5% to around $88 in pre-market trading on Friday. The sell-off comes despite the company's positive organic sales momentum and continued earnings growth expectations for 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.